NovoLog and Tapentadol Extended-Release Tablets
Determining the interaction of NovoLog and Tapentadol Extended-Release Tablets and the possibility of their joint administration.
No interaction was detected between the selected drugs or effects of joint drug administration are currently understudied, and it takes time and accumulated statistics to determine their interaction. A doctor should be consulted to address the issue of joint drug administration.
Generic Name: insulin aspart
Brand name: NovoLog, NovoLog FlexPen, NovoLog PenFill, Fiasp, NovoLOG FlexTouch, Fiasp PenFill, Fiasp FlexTouch
Synonyms: Novolog
Generic Name: tapentadol
Brand name: Nucynta, Nucynta ER
Synonyms: Tapentadol
In the course of checking the drug compatibility and interactions, data from the following reference sources was used: Drugs.com, Rxlist.com, Webmd.com, Medscape.com.
- NovoLog-Tapentadol Hydrochloride
- NovoLog-Tapentadol Tablets
- NovoLog-TaperDex 12-day
- NovoLog-TaperDex 6-day
- NovoLog-TaperDex 7-day
- NovoLog-Tar Distillate Topical
- Tapentadol Extended-Release Tablets-NovoLog FlexPen
- Tapentadol Extended-Release Tablets-Novolog Injection
- Tapentadol Extended-Release Tablets-NovoLog Mix 70/30
- Tapentadol Extended-Release Tablets-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Cartridges and Prefilled Pens))
- Tapentadol Extended-Release Tablets-NovoLog Mix 70/30 (Insulin Aspart Protamine and Insulin Aspart (Vials))
- Tapentadol Extended-Release Tablets-NovoLog Mix 70/30 FlexPen